Changes in cardiac functions in patients treated with parathyroidectomy for secondary hyperparathyroidism
Updates in Surgery · 2024-08 · 76 (4) · 1443-1452
DOI: 10.1007/s13304-024-01812-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Updates in Surgery, online erschienen am 26.03.2024. Verfasst von Sami Benli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Division of Surgical Oncology, Mersin University Medical Faculty, Mersin, Turkey. benlisami@outlook.com. Hauptthemen laut MEDLINE: Parathyroidectomy, Hyperparathyroidism, Secondary, Echocardiography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mersin University.
Abstract (Originalsprache)
Our study aims to investigate the changes in cardiac functions, especially myocardial performance index (MPI), in patients who underwent parathyroidectomy for secondary hyperparathyroidism. Patients who underwent parathyroidectomy for secondary hyperparathyroidism between June 2010 and September 2021 were analyzed retrospectively. The patients were divided into two groups: those who underwent total parathyroidectomy (group 1) and those who underwent subtotal parathyroidectomy (group 2). The groups were compared according to the echocardiogram findings performed in the preoperative period and the postoperative sixth month. In addition, cardiac structure, and systolic and diastolic functions, especially myocardial performance index, were evaluated by echocardiography and Doppler imaging. Thirty-seven patients were examined; 16 (43.2%) underwent total parathyroidectomy, and 21 (56.8%) had subtotal parathyroidectomy performed. Group 1’s mean left ventricular end-systolic diameter (LVES) decreased from 2.53 ± 0.57 to 2.35 ± 0.37 cm after parathyroidectomy. In Group 1, the postoperative value of LVES and end-systolic volume decreased significantly compared to the preoperative period ( p = 0.042, p = 0.008, respectively). EF increased from 59.25 ± 0.05 to 67.81 ± 4.04. In Group 1, EF and EV postoperatively increased significantly compared to the preoperative period ( p = 0.023, p = 0.021, respectively). The mean MPI decreased from 0.45 ± 0.07 to 0.39 ± 0.04 after parathyroidectomy in group 1. In group 2, it decreased from 0.46 ± 0.06 to 0.40 ± 0.04 ( p < 0.001). The present study provides an improvement in myocardial functions after parathyroidectomy. While LVES, EF, ejection volume, end-systolic volume, and MPI improved in both groups, the MPI improvement was more evident in the total parathyroidectomy group. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Division of Surgical Oncology, Mersin University Medical Faculty, Mersin, Turkey. benlisami@outlook.com.
- Department of Cardiology, Mersin University Medical Faculty, Mersin, Turkey.
- Department of General Surgery, Division of Surgical Oncology, Mersin University Medical Faculty, Mersin, Turkey.
- Department of General Surgery, Division of Endocrine Surgery, Mersin University Medical Faculty, Mersin, Turkey.
Förderung
- Mersin University
Zitieren
APA
Benli, S., Yesil, E., Tazeoglu, D., Ozcan, C., Ozcan, I. T., & Dag, A. (2024). Changes in cardiac functions in patients treated with parathyroidectomy for secondary hyperparathyroidism. Updates in Surgery, 76(4), 1443-1452. https://doi.org/10.1007/s13304-024-01812-8
Vancouver
Benli S, Yesil E, Tazeoglu D, Ozcan C, Ozcan IT, Dag A. Changes in cardiac functions in patients treated with parathyroidectomy for secondary hyperparathyroidism. Updates in Surgery. 2024;76(4):1443-1452. doi:10.1007/s13304-024-01812-8
BibTeX
@article{Benli2024,
author = {Benli, Sami and Yesil, Emrah and Tazeoglu, Deniz and Ozcan, Cumhur and Ozcan, Ismail Turkay and Dag, Ahmet},
title = {Changes in cardiac functions in patients treated with parathyroidectomy for secondary hyperparathyroidism},
journal = {Updates in Surgery},
year = {2024},
volume = {76},
number = {4},
pages = {1443--1452},
doi = {10.1007/s13304-024-01812-8}
}
EUVIMED